Rekvina Laboratories P/E Ratio
Rekvina Laboratories (VINRKLB) P/E ratio is not applicable — EPS (TTM) ₹-0.42. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-0.42
Healthcare Peers with Valid P/E Ratios — VINRKLB Comparison
Healthcare sector average P/E 55.21, median 31.04 — VINRKLB excluded (negative EPS).
Sector Average PE
55.21
Sector Median PE
31.04
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see VINRKLB share price.
- Read VINRKLB dividend growth for the complete payout history and dividend yield track record.
- See VINRKLB price to book ratio to compare market price against book value per share.